Subcutaneous Immunoglobulin Therapy for Primary and Secondary Immune Deficiency Diseases


( Last Updated : October 20, 2021)
Project Line:
Reference List
Project Sub Line:
Reference List
Project Number:
RA1194-000

Details


Question

  1. What is the clinical effectiveness of subcutaneous immunoglobulin therapy in patients with primary or secondary immune deficiency diseases?

Key Message

No evidence was identified regarding the clinical effectiveness of subcutaneous immunoglobulin therapy in patients with primary or secondary immune deficiency diseases.